NCAB ad hoc group approves seven new, reissue concepts

The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades ago
Lowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.”

When President Donald Trump on Feb. 3 signed H.R.7148, a package funding most of the federal government through FY26, many in oncology released a long-held sigh of relief.

Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors

The new ad hoc working group of the National Cancer Advisory Board will play a key role in shaping NCI’s extramural priorities, NCI Director Anthony Letai said at the group’s inaugural meeting Feb. 6.

February 06, 2026

Vol.52 No.05

By Claire Marie Porter

NCI

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

Anthony G. Letai’s initiation as the 18th director of the National Cancer Institute wasn’t exactly smooth.

December 05, 2025

Vol.51 No.44

By Jacquelyn Cobb

NCAB approves five reissue concepts

The National Cancer Advisory Board approved five reissue concepts at a meeting Sept. 4.

September 12, 2025

Vol.51 No.33

By Sara Willa Ernst

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

On Sept. 4, Jay Bhattacharya did something NIH directors rarely do: he appeared before the National Cancer Advisory Board, speaking directly with the NCI advisory board about hot-button policy changes taking place under his leadership at NIH.

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January.

September 05, 2025

Vol.51 No.32

By Jacquelyn Cobb

NCAB ad hoc group approves seven new, reissue concepts

YOU MAY BE INTERESTED IN

The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades ago
Lowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.”

Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

NCAB approves five reissue concepts

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

Renew today!

Subscriber content

Never miss an issue!

Login

NCAB ad hoc group approves seven new, reissue concepts

YOU MAY BE INTERESTED IN

The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades agoLowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.”

Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural researchThe group replaced the NCI Board of Scientific Advisors

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

NCAB approves five reissue concepts

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

Never miss an issue!

Login

The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades ago
Lowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.”

Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors